JonesTrading Downgrades Deciphera Pharmaceuticals to Hold, Announces $25.6 Price Target
Deciphera Pharmaceuticals Delist
Deciphera Pharmaceuticals DCPH | 25.59 | Delist |
JonesTrading analyst Soumit Roy downgrades Deciphera Pharmaceuticals (NASDAQ:
DCPH) from Buy to Hold and announces $25.6 price target.